Jaeb Center for Health Research

• Adam R Glassman

  President

Sources: reporter.nih.gov

• NCT04974528

  Collaborator, Phase 3, Completed, 319 people, 23 Jul 2021

• NCT04661358

  Phase 3, Active, not recruiting, 563 people, 10 Dec 2020

• NCT03345901

  Phase 3, Terminated, 18 people, 17 Nov 2017

• DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME

  Phase 3, Completed, 270 people, 25 Oct 2017

• NCT02660242

  Phase 2, Completed, 16 people, 21 Jan 2016

• NCT02411578

  Phase 2, Completed, 26 people, 8 Apr 2015

• NCT02045290

  Phase 3, Completed, 37 people, 24 Jan 2014

• NCT01997411

  Collaborator, Phase 2/3, Completed, 48 people, 28 Nov 2013

• NCT01881828

  Phase 3, Completed, 164 people, 20 Jun 2013

• NCT01190813

  Phase 3, Completed, 139 people, 30 Aug 2010

• NCT00789672

  Phase 2, Completed, 33 people, 13 Nov 2008

Sources: clinicaltrials.gov

• National Eye Institute

  UG1, DRCR Retina Network, UG1EY014231, US$10.5m, 2002–2028, 14 Feb 2025

Sources: reporter.nih.gov